EpiCypher develops and manufactures novel products and tools for epigenetics and chromatin biology research.
EpiCypher has raised $3.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
EpiCypher's investors include BioTools Innovator, One North Carolina Small Business Program.
EpiCypher is headquartered in Chapel Hill, United States.
EpiCypher develops and manufactures novel products and tools for epigenetics and chromatin biology research.
EpiCypher is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EpiCypher — Funding & Investors." VCBacked, July 1, 2024, https://www.vcbacked.co/company/epicypher. Accessed November 11, 2026.
VCBacked. (2024). EpiCypher — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/epicypher
{{cite web |title=EpiCypher — Funding & Investors |url=https://www.vcbacked.co/company/epicypher |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at EpiCypher? Request a listing update